Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Effects of TGF-β signaling in Clear Cell Renal Cell Carcinoma cells.

Boström, Anna-Karin LU ; Lindgren, David LU ; Johansson, Martin LU and Axelson, Håkan LU (2013) In Biochemical and Biophysical Research Communications 435(1). p.126-133
Abstract
Clear cell renal cell carcinoma (ccRCC) is by far the most common type of kidney cancer and is characterized by loss of the tumor suppressor gene von Hippel-Lindau (VHL). ccRCC patients with metastatic disease has poor prognosis and today's therapy is insufficient. The cytokine Transforming Growth Factor-β (TGF-β) has been extensively studied in tumor biology and is believed to serve a variety of functions in tumor progression. We have previously shown that inhibition of NOTCH signaling causes a reduced migratory and invasive capacity of ccRCC cells, at least partly by a cross-talk with the TGF-β pathway. In the present study we aimed to further clarify the role of TGF-β signaling in ccRCC. We investigated the effects of TGF-β pathway... (More)
Clear cell renal cell carcinoma (ccRCC) is by far the most common type of kidney cancer and is characterized by loss of the tumor suppressor gene von Hippel-Lindau (VHL). ccRCC patients with metastatic disease has poor prognosis and today's therapy is insufficient. The cytokine Transforming Growth Factor-β (TGF-β) has been extensively studied in tumor biology and is believed to serve a variety of functions in tumor progression. We have previously shown that inhibition of NOTCH signaling causes a reduced migratory and invasive capacity of ccRCC cells, at least partly by a cross-talk with the TGF-β pathway. In the present study we aimed to further clarify the role of TGF-β signaling in ccRCC. We investigated the effects of TGF-β pathway modulation and showed that TGF-β inhibition attenuates the invasive capacity of ccRCC cells. By performing expression profiling we obtained a gene signature of the TGF-β induced response in ccRCC cells. The expression analyses revealed an extensive overlap between the TGF-β response and genes regulated by the hypoxia inducible factor (HIF). The link between the hypoxic and the TGF-β pathways was further corroborated by functional experiments, which demonstrated that TGF-β pathway activity was attenuated upon reintroduction of functional VHL in ccRCC. (Less)
Please use this url to cite or link to this publication:
author
; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Biochemical and Biophysical Research Communications
volume
435
issue
1
pages
126 - 133
publisher
Elsevier
external identifiers
  • wos:000320012900021
  • pmid:23618868
  • scopus:84878186292
  • pmid:23618868
ISSN
1090-2104
DOI
10.1016/j.bbrc.2013.04.054
language
English
LU publication?
yes
additional info
Department affilation moved from v1000583 (Molecular Tumour Biology) to v1000562 (Department of Translational Medicine) on 2016-01-18 14:41:47.
id
bd9b74ec-2a39-4309-86c0-896ff22dd80d (old id 3733351)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/23618868?dopt=Abstract
date added to LUP
2016-04-01 10:15:29
date last changed
2022-05-13 07:03:59
@article{bd9b74ec-2a39-4309-86c0-896ff22dd80d,
  abstract     = {{Clear cell renal cell carcinoma (ccRCC) is by far the most common type of kidney cancer and is characterized by loss of the tumor suppressor gene von Hippel-Lindau (VHL). ccRCC patients with metastatic disease has poor prognosis and today's therapy is insufficient. The cytokine Transforming Growth Factor-β (TGF-β) has been extensively studied in tumor biology and is believed to serve a variety of functions in tumor progression. We have previously shown that inhibition of NOTCH signaling causes a reduced migratory and invasive capacity of ccRCC cells, at least partly by a cross-talk with the TGF-β pathway. In the present study we aimed to further clarify the role of TGF-β signaling in ccRCC. We investigated the effects of TGF-β pathway modulation and showed that TGF-β inhibition attenuates the invasive capacity of ccRCC cells. By performing expression profiling we obtained a gene signature of the TGF-β induced response in ccRCC cells. The expression analyses revealed an extensive overlap between the TGF-β response and genes regulated by the hypoxia inducible factor (HIF). The link between the hypoxic and the TGF-β pathways was further corroborated by functional experiments, which demonstrated that TGF-β pathway activity was attenuated upon reintroduction of functional VHL in ccRCC.}},
  author       = {{Boström, Anna-Karin and Lindgren, David and Johansson, Martin and Axelson, Håkan}},
  issn         = {{1090-2104}},
  language     = {{eng}},
  number       = {{1}},
  pages        = {{126--133}},
  publisher    = {{Elsevier}},
  series       = {{Biochemical and Biophysical Research Communications}},
  title        = {{Effects of TGF-β signaling in Clear Cell Renal Cell Carcinoma cells.}},
  url          = {{http://dx.doi.org/10.1016/j.bbrc.2013.04.054}},
  doi          = {{10.1016/j.bbrc.2013.04.054}},
  volume       = {{435}},
  year         = {{2013}},
}